ReviewDrug safety2019

Safety and Tolerability of Anti-Angiogenic Protein Kinase Inhibitors and Vascular-Disrupting Agents in Cancer: Focus on Gastrointestinal Malignancies.

Letizia Procaccio et al.PubMed ↗Publisher ↗

No numbers read from the abstract.